64Cu(II)Cl2 solution for injection clinical trials

Use of 64CuCl2 PET/CT Imaging in the selection of patients with prostate cancer in biochemical relapse after prostatectomy, to be successfully treated with salvage radiotherapy on the prostatic bed.

This study looks at a special scan called a 64CuCl2 PET/CT to help doctors decide if a type of radiotherapy is right for men with prostate cancer that has returned after surgery. It aims to see if the scan can predict who will benefit most from this treatment.